Insider · CIK 0001539629
Richard N. Altice
Files at DNMR (Danimer Scientific, Inc.). First filing -, latest -.
In brief
Richard N. Altice files SEC Form 4 as CEO and director at DNMR (Danimer Scientific, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Richard N. Altice has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 14, 2024 | DNMR Danimer Scientific, Inc. | AGrant or award Stock Appreciation Rightsderivative | +300,000 | $0.00 | $0 | 300,000 | Oct 16, 2024 |
| Jul 18, 2024 | DNMR Danimer Scientific, Inc. | AGrant or award Restricted Stock Unitsderivative | +86,957 | $0.00 | $0 | 86,957 | Jul 22, 2024 |
| Apr 15, 2024 | DNMR Danimer Scientific, Inc. | AGrant or award Restricted Stock Unitsderivative | +8,242 | $0.00 | $0 | 8,242 | Apr 17, 2024 |
Questions about Richard N. Altice
Answered from the filings on this page, as of the latest one.
Is Richard N. Altice buying or selling?
Richard N. Altice has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Richard N. Altice's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Richard N. Altice has 0.
Where does Richard N. Altice file Form 4?
Richard N. Altice has filed Form 4 at DNMR (Danimer Scientific, Inc.) as Interim CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.